A Phase I Clinical Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of LG-0317 in Healthy Participants
NCT07522970
·
clinicaltrials.gov ↗
PHASE1
Phase
NOT_YET_RECRUITING
Status
100
Enrollment
OTHER
Sponsor class
Conditions
Healthy Volunteers
Interventions
DRUG:
LG-0317
DRUG:
Placebo
Sponsor
LinGang Laboratory